TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 51 filers reported holding TCR2 THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 20.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,217 | +39.6% | 812,459 | -7.1% | 0.01% | +25.0% |
| Q4 2022 | $872 | -99.9% | 874,853 | +28.1% | 0.00% | -42.9% |
| Q3 2022 | $1,228,000 | -21.8% | 683,114 | +26.1% | 0.01% | -12.5% |
| Q2 2022 | $1,571,000 | +18.8% | 541,875 | +13.0% | 0.01% | +60.0% |
| Q1 2022 | $1,322,000 | +1933.8% | 479,518 | +3250.7% | 0.01% | – |
| Q4 2021 | $65,000 | +364.3% | 14,311 | +710.4% | 0.00% | – |
| Q1 2020 | $14,000 | – | 1,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
| MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
| TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
| Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
| HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
| Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
| Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
| Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
| X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |